Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lapatinib + Trastuzumab in HER2+ Metastatic Breast Cancer
NCT00470704Phase 2Completed
- Sponsor
- Nancy Lin
- Start
- May 2007
- Primary completion
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lapatinib in breast cancer, sponsored by Nancy Lin. Started May 2007; status: completed.
02
Drugs
lapatinib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00470704.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00470704.